CCAT2: A novel oncogenic long non-coding RNA in human cancers
- PMID: 28244168
- PMCID: PMC6529071
- DOI: 10.1111/cpr.12342
CCAT2: A novel oncogenic long non-coding RNA in human cancers
Abstract
Colon cancer-associated transcript 2 (CCAT2) was originally identified as an oncogenic long non-coding RNA in colorectal cancer. Since its discovery, the oncogenic role of CCAT2 has been increasingly demonstrated in human cancers. In this connection, CCAT2 upregulation is frequently reported and very often associated with tumour progression and poor clinical outcomes. Functionally, knockdown of CCAT2 could induce cancer cell apoptosis and suppress cell proliferation and invasiveness, suggesting that CCAT2 might be a therapeutic target. The present review summarized current literature concerning the expression and functional role of CCAT2 in human malignancies.
Keywords: CCAT2; cancers; lncRNAs; long non-coding RNA.
© 2017 John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no competing financial interests.
Similar articles
-
Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.Biomed Pharmacother. 2018 Mar;99:121-127. doi: 10.1016/j.biopha.2018.01.061. Epub 2018 Jan 10. Biomed Pharmacother. 2018. PMID: 29329034
-
The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.Diagn Pathol. 2016 Jun 10;11(1):49. doi: 10.1186/s13000-016-0499-x. Diagn Pathol. 2016. PMID: 27283598 Free PMC article.
-
Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells.Oncotarget. 2016 Dec 6;7(49):81806-81814. doi: 10.18632/oncotarget.13242. Oncotarget. 2016. PMID: 27833083 Free PMC article.
-
Colon cancer associated transcripts in human cancers.Biomed Pharmacother. 2017 Oct;94:531-540. doi: 10.1016/j.biopha.2017.07.073. Epub 2017 Aug 3. Biomed Pharmacother. 2017. PMID: 28779711 Review.
-
Long noncoding RNA CCAT2 can predict metastasis and a poor prognosis: A meta-analysis.Clin Chim Acta. 2017 May;468:159-165. doi: 10.1016/j.cca.2017.03.003. Epub 2017 Mar 3. Clin Chim Acta. 2017. PMID: 28263738 Review.
Cited by
-
Long non-coding RNAs in brain tumors: roles and potential as therapeutic targets.J Hematol Oncol. 2021 May 12;14(1):77. doi: 10.1186/s13045-021-01088-0. J Hematol Oncol. 2021. PMID: 33980320 Free PMC article. Review.
-
The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis.Biosci Rep. 2021 Feb 26;41(2):BSR20203121. doi: 10.1042/BSR20203121. Biosci Rep. 2021. PMID: 33443534 Free PMC article. Review.
-
Long non-coding RNAs: crucial regulators of gastrointestinal cancer cell proliferation.Cell Death Discov. 2018 Apr 27;4:50. doi: 10.1038/s41420-018-0051-8. eCollection 2018. Cell Death Discov. 2018. PMID: 29736267 Free PMC article. Review.
-
Tectorigenin Inhibits Glycolysis-induced Cell Growth and Proliferation by Modulating LncRNA CCAT2/miR-145 Pathway in Colorectal Cancer.Curr Cancer Drug Targets. 2024;24(10):1071-1079. doi: 10.2174/0115680096274757231219072003. Curr Cancer Drug Targets. 2024. PMID: 38243936 Free PMC article.
-
Gemini Curcumin Suppresses Gastric Cancer AGS Cell Proliferation Through Modulation of lncRNA CCAT2 and c-Myc Genes.Turk J Pharm Sci. 2022 Jun 27;19(3):239-245. doi: 10.4274/tjps.galenos.2021.03502. Turk J Pharm Sci. 2022. PMID: 35773976 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources